HCA:NYE-HCA Healthcare, Inc (USD)

COMMON STOCK | Medical Care Facilities | NYE

Last Closing Price

USD 246.79

Change

-2.46 (-0.99)%

Market Cap

USD 82.42B

Volume

1.70M

Avg Analyst Target

USD 233.38 (-5.43%)

Avg User Target

USD
Average Analyst Rating

Verdict

Fundamental Analysis

Verdict

About

HCA Healthcare, Inc., through its subsidiaries, operates as a health care services company in the United States. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy. It also operates psychiatric hospitals, which provide therapeutic programs comprising child, adolescent and adult psychiatric care, and adolescent and adult alcohol and drug abuse treatment and counseling. In addition, the company operates outpatient health care facilities consisting of freestanding ambulatory surgery centers, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, rehabilitation and physical therapy centers, radiation and oncology therapy centers, physician practices, and various other facilities. As of December 31, 2020, it operated 185 hospitals, which included 178 general, acute care hospitals, as well as five psychiatric hospitals and two rehabilitation hospitals; 121 freestanding surgery centers; and 21 freestanding endoscopy centers in 20 states and England. The company was formerly known as HCA Holdings, Inc. HCA Healthcare, Inc. was founded in 1968 and is headquartered in Nashville, Tennessee.

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2021-07-22 )

Largest Industry Peers for Medical Care Facilities

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
FMS Fresenius Medical Care AG & Co..

+0.37 (+0.92%)

USD23.60B 17.67 9.40
OSH Oak Street Health, Inc

+0.64 (+1.06%)

USD14.50B N/A N/A
AGL agilon health, inc

-0.33 (-0.92%)

USD13.97B N/A N/A
UHS Universal Health Services, Inc

-2.93 (-1.91%)

USD13.09B 13.03 8.36
DVA DaVita Inc

+0.01 (+0.01%)

USD12.75B 18.57 10.55
EHC Encompass Health Corporation

-1.07 (-1.34%)

USD7.96B 26.25 12.04
THC Tenet Healthcare Corporation

-2.25 (-3.11%)

USD7.72B 19.17 7.40
CHE Chemed Corporation

+1.82 (+0.38%)

USD7.54B 23.50 15.88
SEM Select Medical Holdings Corpor..

-1.41 (-3.51%)

USD5.42B 16.98 10.24
CANO Cano Health, Inc

+0.57 (+5.21%)

USD5.24B N/A N/A

ETFs Containing HCA

Symbol Name Weight Mer Price(Change) Market Cap
FHH:CA FT AlphaDEX U.S. Health C.. 0.00 % 0.77 %

N/A

USD0.02B
FXH First Trust Health Care A.. 0.00 % 0.61 %

+0.81 (+0.68%)

USD1.52B
IHF iShares U.S. Healthcare P.. 0.00 % 0.42 %

-0.38 (-0.14%)

USD1.44B
HHL:CA Harvest Healthcare Leader.. 0.00 % 0.99 %

+0.05 (+0.59%)

USD0.33B
FHI:CA CI Health Care Giants Cov.. 0.00 % 0.72 %

+0.04 (+0.34%)

USD0.09B
HHL-U:CA Harvest Healthcare Leader.. 0.00 % 0.99 %

+0.04 (+0.46%)

N/A
FHI-B:CA CI Health Care Giants Cov.. 0.00 % 0.74 %

N/A

N/A
ENG:PA BNP Paribas Easy ECPI Glo.. 0.00 % 0.00 %

+0.19 (+0.27%)

USD0.09B
XU61:F BNP Paribas Easy SICAV - .. 0.00 % 0.00 %

+0.23 (+0.34%)

USD0.10B
XU61:XETRA BNP Paribas Easy ECPI Glo.. 0.00 % 0.00 %

+0.20 (+0.30%)

USD0.09B

Market Performance

  Market Performance vs.
Industry/Classification (Medical Care Facilities)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 50.06% 70% C- 92% A-
Dividend Return 0.72% 75% C 27% F
Total Return 50.78% 70% C- 92% A-
Trailing 12 Months  
Capital Gain 94.37% 65% D 89% B+
Dividend Return 1.20% 63% D 18% F
Total Return 95.57% 65% D 88% B+
Trailing 5 Years  
Capital Gain 207.14% 87% B+ 93% A
Dividend Return 6.16% 67% D+ 17% F
Total Return 213.30% 87% B+ 93% A
Average Annual (5 Year Horizon)  
Capital Gain 24.09% 70% C- 86% B
Dividend Return 0.88% 50% F 21% F
Total Return 24.97% 70% C- 86% B
Risk Return Profile  
Volatility (Standard Deviation) 34.86% 55% F 30% F
Risk Adjusted Return 71.63% 90% A- 79% C+
Market Capitalization 82.42B 100% A+ 97% A+
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Medical Care Facilities)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 18.63 44% F 47% F
Price/Book Ratio 293.44 5% F 0% N/A
Price / Cash Flow Ratio 8.93 38% F 47% F
EV/EBITDA 10.09 68% D+ 64% D
Management Effectiveness  
Return on Equity -9,999,999.00% 9% F 4% F
Return on Invested Capital 19.90% 91% A- 91% A-
Return on Assets 10.81% 95% A 94% A
Debt to Equity Ratio 5,383.74% 11% F 0% N/A
Technical Ratios  
Short Ratio 2.69 67% D+ 38% F
Short Percent 1.37% 83% B 70% C-
Beta 1.64 35% F 20% F
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

No discussions yet

User / Independent Analyst Ratings

User Name Target Rating Target Horizon (Months) Target Price User Analysis Date Comment

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Low Dividend Growth

This stock has shown below median dividend growth in the previous 5 years compared to its sector.